Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China.
Rui-Qi WangXiao-Ran LongChun-Lei GeMei-Yin ZhangLong HuangNing-Ning ZhouYi HuRui-Lei LiZhen LiDong-Ni ChenLan-Jun ZhangZhe-Sheng WenShi-Juan MaiHui-Yun WangPublished in: Journal of translational medicine (2020)
In this study, we identified a 4-lncRNA signature that may be a powerful prognosis biomarker and can provide additional survival information to the TNM staging system.